March 28, 2019Open Access

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3

YNYi NiuMinistry of Education of the People's Republic of China ZLZiyou LinTongji University AWArabella WanSun Yat-sen University

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Our findings demonstrate the functional significance of the m6A modification in breast cancer, and suggest that FTO may serve as a novel potential therapeutic target for breast cancer.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Niu et al. (Thu,) studied this question.

synapsesocial.com/papers/69dd43bc7808b00a4799bdc2 https://doi.org/https://doi.org/10.1186/s12943-019-1004-4

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Abstract 4996: The m6A hallmark of cancer: RNA demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation2017 · 4 citations
2CGPS: A machine learning-based approach integrating multiple gene set analysis tools for better prioritization of biologically relevant pathways2018 · 138 citations
3International Variation in Female Breast Cancer Incidence and Mortality Rates2015 · 823 citations
4Posttranscriptional m6A Editing of HIV-1 mRNAs Enhances Viral Gene Expression2017 · 55 citations
5Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor1999 · 6,582 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo